Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 406 participants.

Also called NCT03540355

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 406 participants (enrolled count) (from the registry)
Sponsor
EMS (from the registry)
Registry
  • NCT NCT03540355
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03540355. Randomized; double masking; primary purpose treatment. Start 2021-03-02 (actual); primary completion 2025-01-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment
Acronym
CIPROS20
Condition
Dyslipidemias
Intervention (Drug)
Cipros 20 association
Intervention (Drug)
Crestor 20 mg
Lead sponsor
EMS (class: industry)

Record details

Record id
cardio:ct-nct03540355
Content hash
d973f9ce5ddaa1d8f159a3f3b46a0b207f65b5b458654917568ee65e9086abab